SWAV * Stock Overview
A medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Shockwave Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3,700.00 |
| 52 Week High | US$5,111.53 |
| 52 Week Low | US$3,700.00 |
| Beta | 1.01 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -23.40% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -16.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| SWAV * | MX Medical Equipment | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | -23.4% | 0% | 0% |
Return vs Industry: SWAV * underperformed the MX Medical Equipment industry which returned -2.1% over the past year.
Return vs Market: SWAV * underperformed the MX Market which returned 3.7% over the past year.
Price Volatility
| SWAV * volatility | |
|---|---|
| SWAV * Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: SWAV * has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SWAV *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 1,001 | Doug Godshall | shockwavemedical.com |
ShockWave Medical, Inc., a medical device company, develops intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters for use in our IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter for use in IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system.
Shockwave Medical, Inc. Fundamentals Summary
| SWAV * fundamental statistics | |
|---|---|
| Market cap | Mex$110.74b |
| Earnings (TTM) | Mex$4.17b |
| Revenue (TTM) | Mex$11.49b |
26.5x
P/E Ratio9.6x
P/S RatioIs SWAV * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SWAV * income statement (TTM) | |
|---|---|
| Revenue | US$671.28m |
| Cost of Revenue | US$87.57m |
| Gross Profit | US$583.70m |
| Other Expenses | US$339.82m |
| Earnings | US$243.88m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.61 |
| Gross Margin | 86.95% |
| Net Profit Margin | 36.33% |
| Debt/Equity Ratio | 121.6% |
How did SWAV * perform over the long term?
See historical performance and comparison